Skip to main content
Erschienen in: Clinical Rheumatology 8/2008

01.08.2008 | Original Article

Factors influencing health status and disability of patients with ankylosing spondylitis in the Czech Republic

verfasst von: Š. Forejtová, H. Mann, J. Štolfa, K. Vedral, I. Fenclová, D. Némethová, K. Pavelka

Erschienen in: Clinical Rheumatology | Ausgabe 8/2008

Einloggen, um Zugang zu erhalten

Abstract

The aim of the study was to evaluate factors that influence health status and work disability in patients with ankylosing spondylitis (AS) in the Czech Republic. Data were collected in a retrospective fashion directly from patients with AS using mailed questionnaires containing questions regarding sociodemographic characteristics of patients, the course of their disease, therapy, rehabilitation, quality of life, and ability to work. HAQ-DI (Health Assessment Questionnaire-Disability Index) and BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) were also included in the questionnaires; 1,008 questionnaires were suitable for further statistical analysis. The average age ± SD of patients was 50.2 ± 10.7 years, the average symptom duration was 23.0 ± 11.6 years. Mean time from first symptoms to diagnosis was 9.1 years. Full disability had been awarded to 303 patients (30%) at some point of their disease. Twenty seven percent of patients reported receiving full disability pension for 10 or more years. Four hundred fifty six subjects (45%) were currently or had been previously receiving partial disability pension. Receiving disability pension was more frequent among men (64%) compared to women (56%) (P = 0.012), despite the fact that women had higher BASDAI (P < 0.001) and HAQ-DI (P = 0.004) scores. Patients with a family history of AS had higher BASDAI and HAQ-DI scores (P = 0.001 and P = 0.008, respectively) compared to patients without a family history of AS. BASDAI and HAQ-DI scores correlated with age and duration of illness, younger patients and those with shorter disease duration had lower values. Fifty eight percent of patients reported a BASDAI score ≥4 (current cutoff value for initiation of biological therapy), but only 1% of patients were treated by anti TNF alpha agents within the last year. Seven hundred ninety one patients underwent spa treatment in the previous year; 96% of them experienced improvement of their health condition.
Literatur
1.
Zurück zum Zitat Ward MM (1998) Quality of life in patients with ankylosing spondylitis. Rheum Dis Clin North Am 24:815–827PubMedCrossRef Ward MM (1998) Quality of life in patients with ankylosing spondylitis. Rheum Dis Clin North Am 24:815–827PubMedCrossRef
2.
Zurück zum Zitat Boonen A, de Vet H, van der Heijde D, van der Linden S (2001) Work status and its determinants among patients with ankylosing spondylitis. A systematic literature review. J Rheumatol 28:1056–1062 Boonen A, de Vet H, van der Heijde D, van der Linden S (2001) Work status and its determinants among patients with ankylosing spondylitis. A systematic literature review. J Rheumatol 28:1056–1062
3.
Zurück zum Zitat Ward MM, Weisman MH, Davis JC Jr, Reveille JD (2005) Risk factors for functional limitations in patients with long-standing ankylosing spondylitis. Arthritis Rheum 53:710–717PubMedCrossRef Ward MM, Weisman MH, Davis JC Jr, Reveille JD (2005) Risk factors for functional limitations in patients with long-standing ankylosing spondylitis. Arthritis Rheum 53:710–717PubMedCrossRef
4.
Zurück zum Zitat Chorus AMJ, Boonen A, Miedema HS, Van Der Linden S (2002) Employment perspectives of patients with ankylosing spondylitis. Ann Rheum Dis 61:693–699PubMedCrossRef Chorus AMJ, Boonen A, Miedema HS, Van Der Linden S (2002) Employment perspectives of patients with ankylosing spondylitis. Ann Rheum Dis 61:693–699PubMedCrossRef
5.
Zurück zum Zitat Chorus AM, Miedema HS, Boonen A, Van Der Linden S (2003) Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age. Ann Rheum Dis 62:1178–1184PubMedCrossRef Chorus AM, Miedema HS, Boonen A, Van Der Linden S (2003) Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age. Ann Rheum Dis 62:1178–1184PubMedCrossRef
6.
Zurück zum Zitat Boonen A, van der Heijde D, Landewe R et al (2002) Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries. Ann Rheum Dis 61:429–437PubMedCrossRef Boonen A, van der Heijde D, Landewe R et al (2002) Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries. Ann Rheum Dis 61:429–437PubMedCrossRef
7.
Zurück zum Zitat Boonen A, van der Heijde D, Landewe R et al (2003) Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries. Ann Rheum Dis 62:732–740PubMedCrossRef Boonen A, van der Heijde D, Landewe R et al (2003) Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries. Ann Rheum Dis 62:732–740PubMedCrossRef
8.
Zurück zum Zitat Boonen A, van der Heijde D, Landewe R et al (2003) Costs of ankylosing spondylitis in three European countries: the patient's perspective. Ann Rheum Dis 62:741–747PubMedCrossRef Boonen A, van der Heijde D, Landewe R et al (2003) Costs of ankylosing spondylitis in three European countries: the patient's perspective. Ann Rheum Dis 62:741–747PubMedCrossRef
9.
Zurück zum Zitat Taylor AL, Balakrishnan C, Calin A (1998) Reference centile charts for measures of disease activity, functional impairment, and metrology in ankylosing spondylitis. Arthritis Rheum 41:1119–1125PubMedCrossRef Taylor AL, Balakrishnan C, Calin A (1998) Reference centile charts for measures of disease activity, functional impairment, and metrology in ankylosing spondylitis. Arthritis Rheum 41:1119–1125PubMedCrossRef
10.
Zurück zum Zitat Zink A, Braun J, Listing J, Wollenhaupt J, German Collaborative Arthritis Centers (2000) Disability and handicap in rheumatoid arthritis and ankylosing spondylitis—results from the German rheumatological database. J Rheumatol 27:613–622PubMed Zink A, Braun J, Listing J, Wollenhaupt J, German Collaborative Arthritis Centers (2000) Disability and handicap in rheumatoid arthritis and ankylosing spondylitis—results from the German rheumatological database. J Rheumatol 27:613–622PubMed
11.
Zurück zum Zitat Ward MM (2002) Predictors of the progression of functional disability in patients with ankylosing spondylitis. J Rheumatol 29:1420–1425PubMed Ward MM (2002) Predictors of the progression of functional disability in patients with ankylosing spondylitis. J Rheumatol 29:1420–1425PubMed
12.
Zurück zum Zitat Falkenbach A, Franke A, van der Linden S (2003) Factors associated with body function and disability in patients with ankylosing spondylitis: a cross-sectional study. J Rheumatol 30:2186–2192PubMed Falkenbach A, Franke A, van der Linden S (2003) Factors associated with body function and disability in patients with ankylosing spondylitis: a cross-sectional study. J Rheumatol 30:2186–2192PubMed
13.
Zurück zum Zitat Gran JT, Skomsvoll JF (1997) The outcome of ankylosing spondylitis: a study of 100 patients. Br J Rheumatol 36:766–771PubMedCrossRef Gran JT, Skomsvoll JF (1997) The outcome of ankylosing spondylitis: a study of 100 patients. Br J Rheumatol 36:766–771PubMedCrossRef
14.
Zurück zum Zitat Doran MF, Brophy S, MacKay K, Taylor G, Calin A (2003) Predictors of longterm outcome in ankylosing spondylitis. J Rheumatol 30:316–320PubMed Doran MF, Brophy S, MacKay K, Taylor G, Calin A (2003) Predictors of longterm outcome in ankylosing spondylitis. J Rheumatol 30:316–320PubMed
15.
Zurück zum Zitat Averns HL, Oxtoby J, Taylor HG, Jones PW, Dziedzic K, Dawes PT (1996) Smoking and outcome in ankylosing spondylitis. Scand J Rheumatol 25:138–142PubMedCrossRef Averns HL, Oxtoby J, Taylor HG, Jones PW, Dziedzic K, Dawes PT (1996) Smoking and outcome in ankylosing spondylitis. Scand J Rheumatol 25:138–142PubMedCrossRef
16.
Zurück zum Zitat Ward MM (2002) Functional disability predicts total costs in patients with ankylosing spondylitis. Arthritis Rheum 46:223–231PubMedCrossRef Ward MM (2002) Functional disability predicts total costs in patients with ankylosing spondylitis. Arthritis Rheum 46:223–231PubMedCrossRef
17.
Zurück zum Zitat Dagfinrud H, Mengshoel AM, Hagen KB, Loge JH, Kvien TK (2004) Health status of patients with ankylosing spondylitis: a comparison with the general population. Ann Rheum Dis 63:1605–1610PubMedCrossRef Dagfinrud H, Mengshoel AM, Hagen KB, Loge JH, Kvien TK (2004) Health status of patients with ankylosing spondylitis: a comparison with the general population. Ann Rheum Dis 63:1605–1610PubMedCrossRef
18.
Zurück zum Zitat Dagfinrud H, Kjeken I, Mowinckel P, Hagen KB, Kvien TK (2005) Impact of functional impairment in ankylosing spondylitis: impairment, activity limitation, and participation restrictions. J Rheumatol 32:516–523PubMed Dagfinrud H, Kjeken I, Mowinckel P, Hagen KB, Kvien TK (2005) Impact of functional impairment in ankylosing spondylitis: impairment, activity limitation, and participation restrictions. J Rheumatol 32:516–523PubMed
19.
Zurück zum Zitat Dagfinrud H, Vollestad NK, Loge JH, Kvien TK, Mengshoel AM (2005) Fatigue in patients with ankylosing spondylitis: a comparison with the general population and associations with clinical and self-reported measures. Arthritis Rheum 53:5–11PubMedCrossRef Dagfinrud H, Vollestad NK, Loge JH, Kvien TK, Mengshoel AM (2005) Fatigue in patients with ankylosing spondylitis: a comparison with the general population and associations with clinical and self-reported measures. Arthritis Rheum 53:5–11PubMedCrossRef
20.
Zurück zum Zitat Ozgul A, Peker F, Taskaynatan MA, Tan AK, Dincer K, Kalyon TA (2006) Effect of ankylosing spondylitis on health-related quality of life and different aspects of social life in young patients. Clin Rheumatol 25:168–174PubMedCrossRef Ozgul A, Peker F, Taskaynatan MA, Tan AK, Dincer K, Kalyon TA (2006) Effect of ankylosing spondylitis on health-related quality of life and different aspects of social life in young patients. Clin Rheumatol 25:168–174PubMedCrossRef
21.
Zurück zum Zitat Kobelt G, Andlin-Sobocki P, Maksymowych WP (2006) Costs and quality of life of patients with ankylosing spondylitis in Canada. J Rheumatol 33:289–295PubMed Kobelt G, Andlin-Sobocki P, Maksymowych WP (2006) Costs and quality of life of patients with ankylosing spondylitis in Canada. J Rheumatol 33:289–295PubMed
22.
Zurück zum Zitat Davis JC, van der Heijde D, Dougados M, Woolley JM (2005) Reductions in health-related quality of life in patients with ankylosing spondylitis and improvements with etanercept therapy. Arthritis Rheum 53:494–501PubMedCrossRef Davis JC, van der Heijde D, Dougados M, Woolley JM (2005) Reductions in health-related quality of life in patients with ankylosing spondylitis and improvements with etanercept therapy. Arthritis Rheum 53:494–501PubMedCrossRef
23.
Zurück zum Zitat Hanova P, Pavelka K, Dostal C et al (2004) Incidence and prevalence of rheumatic diseases in a population based study in the Czech republic. Ann Rheum Dis 63(Suppl I):497–498 Hanova P, Pavelka K, Dostal C et al (2004) Incidence and prevalence of rheumatic diseases in a population based study in the Czech republic. Ann Rheum Dis 63(Suppl I):497–498
24.
Zurück zum Zitat Sleglova O, Dusek L, Olejarova M et al (2004) Evaluation of status and quality of life in patients with ankylosing spondylitis—validation of Czech versions of Bath questionnaires—BAS-G, BASDAI and BASFI. Ces Revmatol 12:43–54 Sleglova O, Dusek L, Olejarova M et al (2004) Evaluation of status and quality of life in patients with ankylosing spondylitis—validation of Czech versions of Bath questionnaires—BAS-G, BASDAI and BASFI. Ces Revmatol 12:43–54
25.
26.
Zurück zum Zitat Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291PubMed Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291PubMed
27.
Zurück zum Zitat Zochling J, van der Heijde D, Burgos-Vargas R et al (2006) ASAS/EULAR recommendations for the management of ankylosing spondylitis. ‘ASsessment in AS’ International working group; European League Against Rheumatism Ann Rheum Dis 65(4):442–452PubMedCrossRef Zochling J, van der Heijde D, Burgos-Vargas R et al (2006) ASAS/EULAR recommendations for the management of ankylosing spondylitis. ‘ASsessment in AS’ International working group; European League Against Rheumatism Ann Rheum Dis 65(4):442–452PubMedCrossRef
28.
Zurück zum Zitat van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368PubMedCrossRef van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368PubMedCrossRef
29.
Zurück zum Zitat Fautrel B, Guillemin F (2002) Cost of illness studies in rheumatic diseases. Curr Opin Rheumatol 14:121–126PubMedCrossRef Fautrel B, Guillemin F (2002) Cost of illness studies in rheumatic diseases. Curr Opin Rheumatol 14:121–126PubMedCrossRef
30.
Zurück zum Zitat Mau W, Zeidler H, Mau R et al (1988) Clinical features and prognosis of patients with possible ankylosing spondylitis. Result of a 10-year followup. J Rheumatol 15:1109–1114PubMed Mau W, Zeidler H, Mau R et al (1988) Clinical features and prognosis of patients with possible ankylosing spondylitis. Result of a 10-year followup. J Rheumatol 15:1109–1114PubMed
31.
Zurück zum Zitat Feldtkeller E, Khan MA, van der Heijde D et al (2003) Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 23:61–66PubMed Feldtkeller E, Khan MA, van der Heijde D et al (2003) Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 23:61–66PubMed
32.
Zurück zum Zitat Mau W, Listing J, Huscher D, Zeidler H, Zink A (2005) Employment across chronic inflammatory rheumatic diseases and comparison with the general population. J Rheumatol 32:721–728PubMed Mau W, Listing J, Huscher D, Zeidler H, Zink A (2005) Employment across chronic inflammatory rheumatic diseases and comparison with the general population. J Rheumatol 32:721–728PubMed
33.
Zurück zum Zitat Boonen A, Chorus A, Miedema H, van der Heijde D, Landewé R, Schouten H, van der Tempel H, van der Linden S (2001) Withdrawal from labour force due to work disability in patients with ankylosing spondylitis. Ann Rheum Dis 60:1033–1039PubMedCrossRef Boonen A, Chorus A, Miedema H, van der Heijde D, Landewé R, Schouten H, van der Tempel H, van der Linden S (2001) Withdrawal from labour force due to work disability in patients with ankylosing spondylitis. Ann Rheum Dis 60:1033–1039PubMedCrossRef
34.
Zurück zum Zitat Guillemin F, Briancon S, Pourel J, Gaucher A (1990) Long-term disability and prolonged sick leaves as outcome measurements in ankylosing spondylitis. Possible predictive factors. Arthritis Rheum 33:1001–1006PubMedCrossRef Guillemin F, Briancon S, Pourel J, Gaucher A (1990) Long-term disability and prolonged sick leaves as outcome measurements in ankylosing spondylitis. Possible predictive factors. Arthritis Rheum 33:1001–1006PubMedCrossRef
35.
Zurück zum Zitat Ward M, Kuzis S (2001) Risk factors for work disability in patients with ankylosing spondylitis. J Rheumatol 28:315–21PubMed Ward M, Kuzis S (2001) Risk factors for work disability in patients with ankylosing spondylitis. J Rheumatol 28:315–21PubMed
36.
Zurück zum Zitat Urbanek T, Sitajova H, Hudakova G (1984) Problems of rheumatoid arthritis and ankylosing spondylitis in their labor and life enviroments. Czechoslovak Medicine 7:78–89PubMed Urbanek T, Sitajova H, Hudakova G (1984) Problems of rheumatoid arthritis and ankylosing spondylitis in their labor and life enviroments. Czechoslovak Medicine 7:78–89PubMed
37.
Zurück zum Zitat Lehtinen K (1981) Working ability of 76 patients with ankylosing spondylitis. Scand J Rheumatol 10:263–265PubMedCrossRef Lehtinen K (1981) Working ability of 76 patients with ankylosing spondylitis. Scand J Rheumatol 10:263–265PubMedCrossRef
38.
Zurück zum Zitat McGuigan LE, Hart HH, Gow PJ, Kidd BL, Grigor RR, Moore TE (1984) Employment in ankylosing spondylitis. Ann Rheum Dis 43:604–606PubMedCrossRef McGuigan LE, Hart HH, Gow PJ, Kidd BL, Grigor RR, Moore TE (1984) Employment in ankylosing spondylitis. Ann Rheum Dis 43:604–606PubMedCrossRef
39.
Zurück zum Zitat Calin A, Kennedy LG, Edmunds L, Will R (1993) Familial versus sporadic ankylosing spondylitis: two different diseases? Arthritis Rheum 36:676–681PubMedCrossRef Calin A, Kennedy LG, Edmunds L, Will R (1993) Familial versus sporadic ankylosing spondylitis: two different diseases? Arthritis Rheum 36:676–681PubMedCrossRef
40.
Zurück zum Zitat Gran JT, Skomswoll JF (1997) The outcome of ankylosing spondylitis: a study of 100 patients. Br J Rheumatol 36:766–771PubMedCrossRef Gran JT, Skomswoll JF (1997) The outcome of ankylosing spondylitis: a study of 100 patients. Br J Rheumatol 36:766–771PubMedCrossRef
41.
Zurück zum Zitat Boonen A, Chorus A, Miedema H, van der Heijde D, van der Tempel H, van der Linden S (2001) Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients. Ann Rheum Dis 60:353–358PubMedCrossRef Boonen A, Chorus A, Miedema H, van der Heijde D, van der Tempel H, van der Linden S (2001) Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients. Ann Rheum Dis 60:353–358PubMedCrossRef
42.
Zurück zum Zitat Ribbens C, Vastesaeger N, Brasseur J et al (2006) An epidemiological cross-sectional study of ankylosing spondylitis in Belgium: the ASPECT cohort. Ann Rheum Dis 65(SupplI):539 Ribbens C, Vastesaeger N, Brasseur J et al (2006) An epidemiological cross-sectional study of ankylosing spondylitis in Belgium: the ASPECT cohort. Ann Rheum Dis 65(SupplI):539
43.
Zurück zum Zitat van Tubergen A, Landewe R, van der Heijde D et al (2001) Combined spa-exercise therapy is effective in patients with ankylosing spondylitis: a randomized controlled trial. Arthritis Rheum 45:430–438PubMedCrossRef van Tubergen A, Landewe R, van der Heijde D et al (2001) Combined spa-exercise therapy is effective in patients with ankylosing spondylitis: a randomized controlled trial. Arthritis Rheum 45:430–438PubMedCrossRef
44.
Zurück zum Zitat Gossec L, Dougados M, Phillips C et al (2007) Dissemination and evaluation of the ASAS/EULAR recommendations for the management of Ankylosing Spondylitis: results of a study among 1,507 rheumatologists. Ann Rheum Dis (in press) Nov 29 Gossec L, Dougados M, Phillips C et al (2007) Dissemination and evaluation of the ASAS/EULAR recommendations for the management of Ankylosing Spondylitis: results of a study among 1,507 rheumatologists. Ann Rheum Dis (in press) Nov 29
45.
Zurück zum Zitat Hidding A, de Witte L, van der Linden S (1994) Determinants of self-reported health status in ankylosing spondylitis. J Rheumatol 21:275–278PubMed Hidding A, de Witte L, van der Linden S (1994) Determinants of self-reported health status in ankylosing spondylitis. J Rheumatol 21:275–278PubMed
Metadaten
Titel
Factors influencing health status and disability of patients with ankylosing spondylitis in the Czech Republic
verfasst von
Š. Forejtová
H. Mann
J. Štolfa
K. Vedral
I. Fenclová
D. Némethová
K. Pavelka
Publikationsdatum
01.08.2008
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 8/2008
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-008-0845-9

Weitere Artikel der Ausgabe 8/2008

Clinical Rheumatology 8/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.